Todd H Wasserman

Summary

Affiliation: Kathleen D. Schaum and Associates
Country: USA

Publications

  1. ncbi Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head-and- neck cancer: 2-year follow-up of a prospective, randomized, phase III trial
    Todd H Wasserman
    Department of Radiation Oncology, Washington University, St Louis, MO 63110 1046, USA
    Int J Radiat Oncol Biol Phys 63:985-90. 2005
  2. ncbi A prospective, nonrandomized study of the impact of amifostine on subsequent hypothyroidism in irradiated patients with head and neck cancers
    Imran Zoberi
    Department of Radiation Oncology, Washington University in Saint Louis, St Louis, MO 63110, USA
    Semin Radiat Oncol 12:14-7. 2002
  3. ncbi Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma
    Jeffrey D Bradley
    Radiation Oncology Center, Washington University Medical Center, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 52:49-57. 2002

Detail Information

Publications3

  1. ncbi Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head-and- neck cancer: 2-year follow-up of a prospective, randomized, phase III trial
    Todd H Wasserman
    Department of Radiation Oncology, Washington University, St Louis, MO 63110 1046, USA
    Int J Radiat Oncol Biol Phys 63:985-90. 2005
    ....
  2. ncbi A prospective, nonrandomized study of the impact of amifostine on subsequent hypothyroidism in irradiated patients with head and neck cancers
    Imran Zoberi
    Department of Radiation Oncology, Washington University in Saint Louis, St Louis, MO 63110, USA
    Semin Radiat Oncol 12:14-7. 2002
    ..Local control of disease is achieved in many patients who are at risk for late sequelae of treatment that may diminish quality of life...
  3. ncbi Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma
    Jeffrey D Bradley
    Radiation Oncology Center, Washington University Medical Center, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 52:49-57. 2002
    ..The purpose of this study is to identify prognostic factors in a population of NSCLC patients treated with definitive 3D-CRT...